Preclinical Development of Oral Small Molecule GLP-1 Agonists: Challenges & Solutions

Time: 12:00 pm
day: Day Two

Details:

• Screening paradigms for in vitro cell efficacy, ADME and DMPK
• Validating appropriate in vivo pharmacodynamic models
• In vivo efficacy and safety assessments: early and often
• Clinical Candidate nomination: data from Ambrosia’s proprietary program to be presented

Speakers:

Patrice Lee Patrice Lee, PhD, is a seasoned biopharmaceutical leader with over two decades of experience in drug discovery, development, and translational research. Currently serving as Vice Read more